Project Details
Description
An Open-label Expanded Access trial of Plant cell Expressed Recombinant Human Glucocerebrosidase (prGCD) in Patients with Gaucher Disease Who Require Enzyme Replacement Therapy
Status | Finished |
---|---|
Effective start/end date | 9/17/09 → 12/31/14 |
Funding
- PROTALIX LTD.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.